By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NeuralStem Inc. 

387 Technology Drive

College Park  Maryland  20742  U.S.A.
Phone: 301-314-2671 Fax: 301-405-1064



Company News
NeuralStem Announces Issuance Of Two U.S. Patents 9/7/2017 11:02:39 AM
NeuralStem Reports Second Quarter 2017 Fiscal Results And Provides Clinical And Business Update 8/8/2017 12:48:40 PM
NeuralStem Awarded $~1MM Grant By NIH To Continue Preclinical Research Into The Potential Of NSI-189 For Treatment Of Diabetic Neuropathy 8/2/2017 10:17:34 AM
NeuralStem Announces Proposed Public Offering Of Common Stock And Warrants 7/27/2017 12:44:11 PM
NeuralStem Announces Pricing Of Public Offering Of Common Stock And Warrants 7/27/2017 10:28:40 AM
NeuralStem Added To The Russell Microcap Index 6/26/2017 7:59:41 AM
NeuralStem Reports Last Subject Out In Phase II Trial Of NSI-189 For Major Depressive Disorder 5/18/2017 11:12:57 AM
NeuralStem Reports First Quarter 2017 Fiscal Results Provides Clinical And Business Update 5/11/2017 1:13:58 PM
NeuralStem Expands Phase I Safety Trial Of NSI-566 Neural Stem Cells In Spinal Injury 4/12/2017 10:18:56 AM
NeuralStem Announces The Closing Of $20 Million Strategic Investment From Tianjin Pharmaceutical Group International Holdings Co., LTD. 12/12/2016 7:25:40 AM